Ryo Iwamura
Impact in
- Ophthalmology top 2%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
-
- Inflammatory mediators and NSAID effects
Papers in
-
- Glaucoma and retinal disorders 8
- Retinal Diseases and Treatments 2
-
- Eicosanoids and Hypertension Pharmacology 4
- Co-authors
- Kenji Yoneda (16 shared papers)Naveed Shams (11 shared papers)Noriko Odani‐Kawabata (10 shared papers)Takazumi Taniguchi (7 shared papers)Takeshi Matsugi (5 shared papers)Fumitoshi Asai (2 shared papers)Atsuhiro Sugidachi (1 shared paper)Taketoshi Ogawa (1 shared paper)
- Journals
- Investigative Ophthalmology & Visual Science (7 papers)Journal of Ocular Pharmacology and Therapeutics (4 papers)British Journal of Pharmacology (1 paper)The FASEB Journal (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Ryo Iwamura
16 papers receiving 352 citations
Peers
Comparison fields: 5 of 49
- Ophthalmology 188
- Pharmacology 63
- Physiology 17
- Cardiology and Cardiovascular Medicine 67
- Internal Medicine 10
Countries citing papers authored by Ryo Iwamura
This map shows the geographic impact of Ryo Iwamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Iwamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Iwamura more than expected).
Fields of papers citing papers by Ryo Iwamura
This network shows the impact of papers produced by Ryo Iwamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Iwamura. The network helps show where Ryo Iwamura may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryo Iwamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 87 | |
| 2 | 2018 | 71 | |
| 3 | 2018 | 66 | |
| 4 | 2018 | 40 | |
| 5 | 2020 | 30 | |
| 6 | 2020 | 17 | |
| 7 | 2021 | 16 | |
| 8 | Safety and Efficacy of DE-117, a Selective EP2 Agonist in a Phase 2a Study | 2015 | 9 |
| 9 | DE-117, a selective EP2 agonist, lowered intraocular pressure in animal models | 2015 | 6 |
| 10 | Pharmacokinetics, Safety and IOP Lowering Profiles of omidenepag isopropyl, a Selective EP2 Agonist in Healthy Japanese and Caucasian Volunteers (Phase I Study) | 2017 | 5 |
| 11 | 2023 | 5 | |
| 12 | 2020 | 4 | |
| 13 | 2001 | 4 | |
| 14 | Effects of Omidenepag, a Selective EP2 Receptor Agonist on Adipocyte Differentiation | 2019 | 1 |
| 15 | Omidenepag isopropyl, a selective EP2 agonist, shows additive intraocular pressure (IOP)-lowering effects when used concomitantly with existing anti-glaucoma drugs in animal models | 2017 | 1 |
| 16 | Effects of a selective EP2 receptor agonist, omidenepag isopropyl, on eyelash growth in mice | 2018 | 1 |
About Ryo Iwamura
Ryo Iwamura is a scholar working on Ophthalmology, Biochemistry, Pharmacology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 16 papers that have together received 363 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (8 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Inflammatory mediators and NSAID effects (3 papers), Ocular Surface and Contact Lens (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Retinal Diseases and Treatments (2 papers), Chemokine receptors and signaling (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Ophthalmology (188 citations), Pharmacology (63 citations), Physiology (17 citations), Cardiology and Cardiovascular Medicine (67 citations) and Internal Medicine (10 citations). Ryo Iwamura has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kenji Yoneda, Naveed Shams, Noriko Odani‐Kawabata, Takazumi Taniguchi, Takeshi Matsugi, Fumitoshi Asai, Atsuhiro Sugidachi, Taketoshi Ogawa, Ken‐ichi Otsuguro and Hiroyuki Koike. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Journal of Ocular Pharmacology and Therapeutics, British Journal of Pharmacology, The FASEB Journal and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.